In the third pathway, the tumor cells retain the wild type form of IDH and rapidly acquire multiple complex genetic alterations with a tendency to progress into a glioblastoma (GBM), a WHO grade IV astrocytoma [5]. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).